A multi-disciplinary team from Imperial College Healthcare NHS Trust (ICHT) has been recognised for their innovative approach to improving patient care through technology, with an award from the British Medical Journal (BMJ). The team won the Digital Innovation Team of the Year for creating an algorithm to analyse the free text comments made by patients […]
The NIHR Imperial BRC is committed to supporting equal opportunity. We have identified a potential unmet need to enable senior NIHR Imperial BRC researchers on maternity, adoption, surrogacy and/or shared parental leave to continue their research during their temporary absence. We will appoint a fixed-term research technician to support a Clinician Scientist, Intermediate Fellow, Senior […]
Hepatocellular carcinoma (also called hepatoma or HCC) is the most common type of primary liver cancer. In the UK, there are over 5,500 new cases diagnosed each year, which is around 16 patients each day. Worryingly, the incidence of HCC is dramatically increasing: up 150% since the 1990s and this relates in part to rising […]
Imperial BRC researchers have designed a new way to deliver antibiotics that both targets and kills bacteria that have evolved a mechanism of resistance to frontline treatment drugs. Since their discovery, antibiotics have become a cornerstone of modern medicine, saving millions of lives. However, excessive and inappropriate use means many antibiotics are rendered ineffective with […]
The Microbiome@Imperial Network was launched on 9th May 2019 at Imperial College London, following a successful bid led by Professor Marc-Emmanuel Dumas, with Dr Thomas Bell, Dr Michael Cox, Professor Julian Marchesi and Professor Miriam Moffatt. The Network will bring together a critical mass of researchers across Faculties in a strategic effort to share knowledge, foster collaborations and […]
Harnessing world-leading discovery science and clinical expertise to develop innovative therapeutics, devices and diagnostics for healthcare
Examples of research projects testing out new drugs, devices and diagnostics in humans for the first time. The BRC is specifically aimed at supporting these kinds of experimental medicine studies.
The NIHR Imperial BRC has developed a range of innovative device technologies, in collaboration with scientists in our Faculties of Natural Sciences and Engineering. Some of the most recent are highlighted here.
The NIHR Imperial BRC has a strong, successful track record of collaborating with life sciences and other related industries, academic institutions, charities and research organisations. Most recent examples can be found here.